Skip to content

H.R. 447 · 118th Congress (2023–2025)

MMEDS Act of 2023

This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.

Show official title

To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.R. 447’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Jenniffer [R-PR-At Large] Rescom. González-Colón
Cosponsors
3 cosponsors

1 original · 2 later

  1. Rep. Maria Elvira Salazar (R-FL-27)· Original · Jan 24, 2023
  2. Rep. Carlos A. Gimenez (R-FL-28)· Later · Sep 26, 2023
  3. Rep. Nicole Malliotakis (R-NY-11)· Later · Oct 26, 2023
Policy area
Taxation
Subjects
  • Aging
  • Business expenses
  • Business investment and capital
  • Cardiovascular and respiratory health
  • Community life and organization
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Economic development
  • 22 more
    • Emergency medical services and trauma care
    • Government studies and investigations
    • Health technology, devices, supplies
    • Housing and community development funding
    • Immunology and vaccination
    • Income tax credits
    • Income tax deductions
    • Industrial facilities
    • Infectious and parasitic diseases
    • Manufacturing
    • Medical research
    • Medical tests and diagnostic methods
    • Minority and disadvantaged businesses
    • Minority health
    • Poverty and welfare assistance
    • Public-private cooperation
    • Research administration and funding
    • Research and development
    • Strategic materials and reserves
    • Unemployment
    • Veterans' medical care
    • Wages and earnings

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources
  3. Expired

    Introduced → Referred to House Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 24, 2023
  2. HouseWays and MeansReferred Jan 24, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. MMEDS Act of 2023

    Display title, Short title · Introduced in House

  2. Medical Manufacturing, Economic Development, and Sustainability Act of 2023

    Short title · Introduced in House

  3. To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.

    Official title · Introduced in House